O vírus ZIKA pertence ao gênero Flavivírus e diversos trabalhos têm demonstrado que a infecção por esse vírus está associada com o desenvolvimento de anomalias congênitas fetais e doenças neurológicas como casos de microcefalia e de síndrome de Guillan-Barré. Com intuito de entender os mecanismos imunológicos de controle da replicação viral e na patogênese da doença, o objetivo do trabalho foi estabelecer um modelo experimental de infecção por vírus ZIKV em animais imunocompetentes e investigar a migração de leucócitos para o sistema nervoso central durante a infecção por esse vírus. Os animais C57BL/6 infectados por ZIKV apresentaram um aumento da carga viral no sistema nervoso central (SNC) após 24 horas de infecção e uma redução significativa após 48 e 72 horas de infecção. No entanto, os animais deficientes do receptor de IFN tipo I (IFNAR-/-) apresentaram uma alta carga viral após 48 e 72 horas de infecção. Nossos dados mostram que os animais IFNAR-/- são altamente suscetíveis a infecção com 100% de mortalidade na fase aguda da doença, enquanto os animais C57BL/6 são resistentes a infecção com 100% sobrevida por mais de 30 dias de infecção. A infecção com ZIKA induziu o recrutamento de duas subpopulações de monócitos CD11b+Ly6Chi e CD11b+Ly6Clo para o SNC de maneira dependente da sinalização de IFN tipo I. Uma vez que, os animais C57BL/6 apresentaram um aumento de monócitos no SNC após 48 horas de infecção, enquanto que os animais IFNAR-/- apresentaram o recrutamento dessas células somente após 72 horas de infecção. De maneira interessante, o recrutamento dos monócitos culminou com um aumento da expressão das citocinas IL-6 e IL-18 no SNC de animais C57BL/6, enquanto que a expressão dessas citocinas não foi encontrada no SNC de animais IFNAR-/-, sugerindo a importância da via de sinalização de IFN tipo I para a produção dessas citocinas. E por fim, demostramos que a migração dos monócitos para SNC de animais infectados com vírus ZIKA é dependente da produção de CCL2 produzida no cérebro de animais infectados e da expressão dos receptores de quimiocinas CCR2 e CCR5. Uma vez que, animais deficientes para CCR2 (CCR2-/-) e CCR5 (CCR5-/-) apresentaram uma redução da frequência dos monócitos CD11b+Ly6Chi para o SNC em comparação aos animais C57BL/6 após a infecção. De maneira geral, nossos dados mostram que os animais C57BL/6 são resistentes à infecção por ZIKV, uma vez que a via de sinalização de IFN do tipo I está envolvida no recrutamento de monócitos inflamatórios para SNC e consequente controle da replicação viral. O desenvolvimento de um modelo experimental de infecção por vírus ZIKV abre perspectivas para o entendimento dos mecanismos de controle da replicação viral e sobre a patogênese da doença. / The ZIKA virus belongs to the genus Flavivirus, several studies have demonstrated that the infection by this virus is associated with the development of fetal congenital anomalies and neurological diseases, such as microcephaly and Guillan-Barré syndrome. In order to elucidate the immunological mechanisms of the viral replication control and the disease pathogenesis, the study aim was to establish an experimental model of ZIKV infection in immunocompetent animals and investigate the leukocytes migration to the central nervous system during this virus infection. ZIKV infected C57BL/6 animals demonstrated an increased viral load in the central nervous system (CNS) after 24 hours of infection and a significant reduction after 48 and 72 hours of infection. However, type I INF receptor deficient mice (IFNAR-/-) had a high viral load after 48 and 72 hours of infection. Our data demonstrated that IFNAR-/- animals are highly susceptible to infection with 100% mortality during the acute phase of the disease, while C57BL/6 mice are resistant with 100% survival for more than 30 days of infection. ZIKA infection induced the recruitment of two monocytes subpopulation CD11b+Ly6Chi and CD11b+Ly6Clo to the CNS in a dependent manner of type I INF signaling. C57BL/6 mice showed an increase of monocytes in the CNS after 48 hours of infection, whereas IFNAR-/- mice recruited these cells only after 72 hours of infection. Interestingly, the monocytes recruitment culminated in an increased expression of IL-6 and IL-18 in C57BL/6 mice CNS, while these cytokines expression was not observed in the CNS of IFNAR-/- animals, thus suggesting the importance of type I INF signaling pathway for these cytokines production. Finally, we have demonstrated that the monocytes migration to the CNS from animals infected with ZIKA virus is dependent of CCL2 production in the brain of infected animals, as well as the expression of the chemokine receptors CCR2 and CCR5. Given that CCR2 (CCR2-/-) and CCR5 (CCR5-/-) deficient animals demonstrated a frequency reduction of CD11b+Ly6Chi monocytes to the CNS compared to C57BL/6 mice after infection. Overall, our data demonstrate that C57BL/6 animals are resistant to ZIKV infection, since the type I INF signaling pathway is involved in the inflammatory monocytes recruitment to the CNS and subsequent viral replication control. The development of an experimental model of ZIKV infection open perspectives for the understanding of viral replication control mechanisms and disease pathogenesis.

During normal cell development, many genes are activated and repressed, usually through epigenetic mechanisms. These are modifications of the DNA and protein within the nucleus that result in changes in gene expression without alteration in DNA sequence. Key proteins for epigenetic modifications are the histone proteins bound to DNA in the nucleus. The best-characterised epigenetic complexes that modify histone proteins are the polycomb group proteins (PcG), comprising polycomb repressive complexes 1 (PRC1) and 2 (PRC2). The repressive modifications generated by these complexes can be removed, and the blocked genes reactivated, by enzymes that are the subject of this project. PRC1 repressive marks are removed by deubiquitinases USP12, USP16 and BAP1, whereas PRC2 marks are removed by demethylases KDM6A, KDM6B and potentially UTY. During the development of cancer, the regulation of many genes becomes abnormal, allowing the cells to escape normal growth restrictions. In this thesis, the expression of this set of chromatin-modifying enzymes in a leukaemia cell line was investigated. The FANTOM consortium has been helping to understand patterns of gene expression for over 10 years. The FANTOM4 dataset described changes in gene expression and promoter usage during differentiation of the THP-1 acute monocytic leukaemia cell line, using CAGE (Cap Analysis of Gene Expression) technology. This human monocyte-like cancer cell line can be stimulated with phorbol esters to halt proliferation and differentiate into macrophages. However, the FANTOM4 time course did not capture detailed mechanisms of regulatory factors in macrophage differentiation due to sparse time points and low read coverage. The main aim of this project was therefore to repeat the time course with tighter time points and deeper sequencing of the transcriptome to develop a very precise picture of sequential activation of gene expression, transcription start site (TSS) usage and the activity of enhancers during the transition from proliferating monocytes to differentiated macrophage phenotype of the THP-1 leukaemia cell line, using CAGE. The focus of this research was on the chromatin-modifying enzymes, but other key cell cycle and macrophage genes have also been examined. The differentiation time course was repeated in triplicate. RNA was extracted and CAGE libraries generated for 18 time points, including the 6 originally studied in FANTOM4. Sequencing results were analysed and normalised using bioinformatics tools. It was shown that analysing 8 samples on one Illumina HiSeq 2500 lane yielded enough read coverage to detect activity from even low expression TSSs, such as those associated with enhancer activity. Clusters of genes which were up- and downregulated at different time points during the differentiation process were identified and characterised. CAGE results for key genes encoding chromatin modifying enzymes and macrophage markers were validated by qRT-PCR. There was a rapid increase of histone demethylase KDM6B mRNA once differentiation was initiated. Histone deubiquitinase USP12 mRNA was also upregulated early in the process. Histone deubiquitinase BAP1 mRNA shows an interesting cyclic regulation pattern which was not seen in the more limited samples of FANTOM4. These interesting chromatin-modifying enzymes and their close paralogues (deubiquitinases USP12, USP16 and BAP1, together with demethylases KDM6A, KDM6B and UTY) were investigated by bioinformatics and genetic tools. USP16 knockout THP-1 cell line was successfully created using CRISPR-Cas9 and its ability to differentiate into macrophages was examined using cell cycle analysis and CAGE sequencing. The USP16 knockout cell line, along with siRNA knock downs of USP12, USP16 and BAP1, was also compared to wildtype THP-1 differentiation using CAGE. Unfortunately, creating other mutant THP-1 cell lines was unsuccessful due to low THP-1 viability after single cell sorting. Investigating KDM6A, KDM6B and UTY using bioinformatics showed that UTY and KDM6A gene expression is positively correlated and this is disrupted in cancer samples. Gene expression and sequence comparison suggested that KDM6A and UTY are coregulated and may act in a similar way in histone demethylation. In summary, the results in this thesis show the transcriptomic changes as the leukaemia cell line ceases proliferation and commences differentiation. Detailed examination suggests that histone modifications are important in the transition between proliferation and differentiation and provide better understanding of regulatory factors in macrophage differentiation and leukaemia.

Estomatite protética associada a Cândida (EPC), a lesão mais frequente em usuários de próteses removíveis, principalmente os idosos, caracteriza-se por uma inflamação da mucosa bucal que suporta a prótese. Está fortemente associada com Candida Albicans, bem como com fatores locais e sistêmicos, como a deficiência da resposta imune. Os monócitos são importantes na resposta protetora contra o fungo, produzindo citocinas que recrutam e ativam leucócitos. Existem alterações funcionais dessas células com o avanço da idade. Não foi possível encontrar na literatura dados referentes à função imunomodulatória dos monócitos de idosos com EPC. O presente trabalho pretendeu avaliar a produção de citocinas por essas células, estimuladas in vitro com C. albicans, obtidas do sangue periférico de idosos usuários de prótese total superior (PTS) com EPC, comparando-se com idosos usuários de PTS sem EPC, e com idosos e jovens não usuários de PTS. Os monócitos isolados foram cultivados em placas de cultura de 24 poços, na ausência ou presença de lipopolissacarídeo (LPS) ou C. albicans ATCC 90028 morta pelo calor. Após 18 horas, o sobrenadante foi coletado e submetido ao ensaio de imunoabsorção por ligação enzimática (ELISA) para dosagem das citocinas pró- inflamatórias fator de necrose tumoral- (TNF-), interleucina-6 (IL-6), IL-1, CXCL8 e proteína quimiotática de monócito (MCP-1), e anti-inflamatórias IL-10 e fator transformador de crescimento- (TGF-). Os resultados estão expressos como média ± desvio padrão dos valores obtidos para cada grupo, e foram analisados por meio de testes estatísticos não-paramétricos. Valores de p<0,05 foram considerados estatisticamente significativos. Os resultados demonstraram, de uma forma geral, alterações nos monócitos oriundos dos idosos com EPC, em comparação aos outros grupos: menor produção espontânea de CXCL8 e de MCP-1; menores níveis de TNF-, de IL-6, de IL-1, de CXCL8, de MCP-1 e de IL-10, após estímulo com LPS; e menor produção de TNF- e de IL-6, após estímulo com C. albicans. Comparando-se idosos e jovens, independente da presença de EPC, os resultados revelaram alterações nos monócitos dos idosos: uma menor produção de TGF-, espontânea e após estímulo com C. albicans. Em conclusão, a disfunção na produção in vitro de citocinas pró e anti-inflamatórias pelos monócitos de idosos com EPC pode representar um aspecto adicional associado à suscetibilidade ao desenvolvimento e à persistência da EPC. Ainda, a disfunção nos monócitos dos grupos de idosos, quanto à produção in vitro de TGF-, pode representar aspectos referentes à imunossenescência. / Candida-associated denture stomatitis (DS), the most frequent lesion among denture wearers, especially the elderly, is characterized by inflammation of the denture-bearing mucosa. It is strongly associated with Candida albicans, as well as with local and systemic factors, such as impaired immune response. Monocytes are important in the protective immune response against the fungus, by the production of cytokines that recruit and activate leukocytes. There are functional changes of these cells with advancing age. No data were found in the literature concerning the immunomodulatory function of these phagocytes in elderly patients with DS. This study aimed to evaluate the cytokine production by monocytes, challenged in vitro with C. albicans, obtained from peripheral blood of elderly denture wearers with DS, compared with elderly denture wearers without DS and elderly and young non-denture wearers. The isolated monocytes were cultivated in 24-well flat-bottomed culture plates, in the absence or presence of lipopolysaccharide (LPS) or heat-killed C.albicans ATCC 90028. After 18 hours, the supernatant was collected and submitted to the enzyme-linked immunosorbent assay (ELISA) for determination of the pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), CXCL8, IL-1, monocyte chemotactic protein-1 (MCP-1) and anti-inflammatory cytokines IL-10 and transforming growth factor- (TGF-). The results are expressed as mean ± standard deviation of the values obtained for each group, and were analyzed using nonparametric statistical tests; p values <0.05 were considered statistically significant. The results demonstrated, in general, changes in monocytes from the elderly with DS, as compared to other groups: lower spontaneous production of CXCL8 and MCP-1; lower levels of TNF-, IL-6, IL-1, CXCL8, MCP-1 and IL-10 after stimulation with LPS; and reduced production of TNF- and IL-6 after stimulation with C. albicans. Comparing young and old, regardless of the presence of DS, the results revealed changes in the monocytes of the elderly: a lower production of TGF-, spontaneous and after stimulation with C. albicans. In conclusion, the dysfunctional in vitro production of pro- and anti-inflammatory cytokines by monocytes from elderly patients with EPC may represent an additional aspect associated with susceptibility to the development and to the persistence of DS. Still, the dysfunction in monocytes of elderly groups, regarding the in vitro production of TGF-, may represent aspects related to immunosenescence.

A melatonina (MLT) é um hormônio responsável pela regulação dos ritmos circadianos, com ampla atuação na fisiologia animal, incluindo os seres humanos. Sua ação moduladora sobre o sistema imune possibilitou estudar seu efeito sobre a estimulação de monócitos na diferenciação em células dendríticas (DCs). Monócitos estimulados com MLT, durante a etapa de adesão de duas horas, apresentaram aumentada presença dos receptores para citocinas GM-CSF, IL-4 e TNF-a, necessários à geração de DCs in vitro. DCs geradas sob estímulo de MLT mostraram um aumento nas moléculas de membrana como CD40, CD80 e CD83. Foram detectadas as citocinas IL-6, IL-8 e IL-10 nos sobrenadantes de DCs imaturas, bem como IL-6, IL-8 e TNF-a para as DCs maduras. Lys estimulados por estas DCs mostraram um elevado índice de proliferação e detectou-se variação nas concentrações das citocinas IL-2, IL-4, IL-6, IL-10, TNF-a e IFN-g, dos sobrenadantes das co-culturas. O uso do inibidor da MLT, Luzindol mostrou tendência a inibição dos efeitos desse hormônio. / Melatonin (MLT) is a hormone responsible for the circadian rhythm regulation, with wide range of actions in animal physiology, including the human beings. Its modulatory action on immune system permited to study its effects on monocyte stimulation to differentiate into dendritic cells (DCs). Monocytes stimulated with MLT, kept for two hours adhesion time, presented enhanced cytokine membrane receptors for GM-CSF, IL-4, TNF-a, needed to in vitro DCs generation. DCs obtained by MLT stimuli show an enhanced presence of membrane molecules, as CD40, CD80 and CD83. The cytokines IL-6, IL-8 e IL-10 were present in the supernatants of imature DCs, as well the IL-6, IL-8 e TNF-a in mature DCs supernatants. Lymphocytes supernatants from DCs co-culture showed an enhanced proliferation index and, were detected a variation for IL-2, IL-4, IL-6, IL-10, TNF-a e IFN-g cytokines. The MLT inhibitor Luzindole show a tendency to inhibition of this hormone.

Investigamos o agonista de Guanilato Ciclase solúvel, BAY 41-2272, como alternativa para compensar falhas nas funções de monócitos. Avaliamos in vitro o efeito do fármaco em células humanas de linhagem e de sangue periférico. O BAY, em células THP-1 e monócitos, aumentou a expressão de CD11b, CD18, CD14, TLR4, TLR2 e CD163 e induziu a produção de TNF-<font face=\"Symbol\">a, IL-1<font face=\"Symbol\">b, IL-6 e IL-12p70. Além disso, o fármaco aumentou a expressão gênica (CYBB, CYBA e NCF2) e protéica (p67PHOX e gp91PHOX) da NADPH oxidase. Ainda, o BAY ativa a via do NF-kB (p65) (dependente de PKG). Mais importante, o fármaco aumentou a atividade microbicida de monócitos de pacientes com DGC e deficiência de MPO a S. aureus e C. albicans. Em animais, o BAY 41-2272 induziu intenso influxo de macrófagos para o peritônio e inflamação. Ainda, potencializou o espraiamento, atividade fagocítica, atividade microbicida, produção espontânea de óxido nítrico e de peróxido de hidrogênio induzida por PMA, em macrófagos peritoneais, aumentando a proteção dos animais desafiados com C. albicans. Em conjunto, nossos resultados confirmam o potencial do BAY 41-2272, ou sua via (GCs/PKG), como alternativa para o desenvolvimento de terapias contra infecções. / We investigated the soluble guanylate cyclase agonist, BAY 41-2272, as an alternative to compensate for failures in of monocytes function. We evaluated the in vitro effect of the drug on human cells lines and peripheral blood cells. The BAY increased expression of CD11b, CD18, CD14, TLR4, TLR2 and CD163 and induce the production of TNF-<font face=\"Symbol\">a, IL-1<font face=\"Symbol\">b, IL-6 and IL-12p70 in THP-1 cells and monocytes. Furthermore, the drug increased NADPH oxidase gene (CYBB, CYBA and NCF2) and protein (gp91phox and p67phox) expression. Also, BAY activates the PKG-dependent NF-kB pathway (p65). More importantly, the drug increased microbicidal activity against S. aureus and C. albicans of monocytes from patients with CGD and MPO deficiency. In animals, BAY 41-2272 induced intense influx of macrophages to the peritoneum and inflammation. BAY potentiated the spreading, phagocytic activity, microbicidal activity, spontaneous production of nitric oxide and PMA-induced hydrogen peroxide release by peritoneal macrophages, increasing host protection against C. albicans. Taken together, our results confirm the potential of BAY 41-2272, or its pathway (sGC / PKG), as an alternative for the development of therapies against infections.

<p>Prostaglandin (PG) E₂ is an eicosanoid derived from the polyunsaturated twenty carbon fatty acid arachidonic acid (AA). PGE₂ has physiological as well as pathophysiological functions and is known to be a key mediator of inflammatory responses. Formation of PGE₂ is dependent upon the activities of three specific enzymes involved in the AA cascade; phospholipase A₂ (PLA₂), cyclooxygenase (COX) and PGE synthase (PGEs). Although the research within this field has been intense for decades, the regulatory mechanisms concerning the PGE₂ synthesising enzymes are not completely established.</p><p>PGE₂ was investigated in human monocytes with or without lipopolysaccharide (LPS) pre-treatment followed by stimulation with calcium ionophore, opsonised zymosan or phorbol myristate acetate (PMA). Cytosolic PLA₂a (cPLA₂a) was shown to be pivotal for the mobilization of AA and subsequent formation of PGE₂. Although COX-1 was constitutively expressed, monocytes required expression of COX-2 protein in order to convert the mobilized AA into PGH₂. The conversion of PGH₂ to the final product PGE₂ was to a large extent due to the action of microsomal PGEs-1 (mPGEs-1). In addition, experiments with inhibitors of extracellular signal regulated kinase and p38 activation, indicated that phosphorylation of cPLA₂α was markedly advantageous for the formation of PGE₂.</p><p>Ellagic acid, a natural polyphenolic compound found in fruits and nuts, was shown to inhibit stimuli induced release of PGE₂ in human monocytes. The effect of ellagic acid was not due to a direct effect on the activities of the enzymes but rather to inhibition of the LPS-induced protein expression of COX-2, mPGEs-1 and cPLA₂a.</p>

<p>Cancer metastasis is the cause of about 90% of cancer patients' deaths. Despite significant improvements in the past three decades in understanding the molecular bases of oncogenic transformation of cancer cells, little is known about the molecular mechanisms underlying tumour cells' alteration of their microenvironment, entrance into the circulation, and colonization of distant organs. In recent years, accumulating evidence has indicated that tumour microenvironment, which consists of a variety of cell types and extracellular matrix components&#65292;plays an important role in regulating the metastatic abilities of carcinoma cells. Co-opted by cancer cells, those stromal cells promote tumour progression via multiple mechanisms, including enhancement of tumour invasiveness, elevation of angiogenesis, and suppression of immune surveillance activity. </p><p>Using a series of human breast cancer cell lines with different metastatic potentials <italic>in vivo</italic>, we performed an unbiased screen examining expression of miRNAs, and found that miR-126 and miR-126*, whose expression are regulated by methylation of the promoter of their host gene Egfl7 inside tumour cells, were significantly negatively correlated with metastatic potential. Using both mouse xenograft models and <italic>in vitro</italic> assays, we showed that this pair of miRNAs suppressed breast cancer metastasis through shaping the tumour microenvironment without changing tumour cell autonomous properties. Specifically, miR-126 and miR-126* act independently to suppress the sequential recruitment of mesenchymal stem cells (MSCs) and inflammatory monocytes into the primary tumour stroma, consequently inhibiting lung metastasis by breast tumour cells. Mechanistically, these miRNAs directly inhibit the production of stromal cell-derived factor-1 alpha (Sdf-1&alpha;, also known as Cxcl12), and indirectly suppress the expression of chemokine (C-C motif) ligand 2 (Ccl2) by the cancer cells within the tumour mass in an Sdf-1&alpha;-dependent manner. In addition, in contrast with the majority of reports which have shown incorporation of only the guiding strand of the miRNA duplex into the mRNA-targeting RNA induced silencing complex (RISC), both strands of the miR-126 RNA duplex are maintained at a similar level and suppress Sdf-1&alpha; expression independently. </p><p>Collectively, we have determined a dynamic process by which the composition of the primary tumour microenvironment could be altered via a change in the expression of two tumour-suppressive miRNAs derived from a single miRNA precursor to favor metastasis by breast cancer cells. Importantly, this work provides a prominent mechanism to explain the clinical correlation between reduced expression of miR-126/126* and poor metastasis-free survival of breast cancer patients.</p> / Dissertation

L'obésité est associée à une inflammation de bas grade et à une augmentation du nombre de monocytes circulants. Ces cellules sont des acteurs majeurs de l'immunité innée. Chez la souris, ils se subdivisent en deux sous-populations : les monocytes Gr1high et les Gr1low. Des études récentes suggèrent que ces 2 sous-populations exercent des fonctions distinctes mais leur rôle respectif dans la physiopathologie de l'obésité est à ce jour inconnu. Nos travaux chez la souris démontrent qu'un régime riche en graisse induit une monocytose principalement due à l'expansion de monocytes Gr1low et une forte augmentation de l'intégrine CD11c spécifiquement sur les Gr1low. A l'aide de différents modèles murins dans lesquels la population de monocytes Gr1low est soit diminuée (souris déficientes pour CX3CR1), soit augmentée (souris CD11c-hBcl2), nous avons mis en évidence une corrélation entre les monocytes Gr1low et le poids et l'insulinorésistance. En effet, les souris déficientes pour CX3CR1 ont une augmentation de l'insulinorésistance malgré une moindre prise de poids mais alors que les souris CD11c-hBcl2 sont plus insulinosensibles que les contrôles. De plus, chez les souris CD11c-hBcl2/CX3CR1 KI, une restauration partielle des monocytes Gr1low est associée à une restauration complète du poids. Nos données suggèrent fortement que les monocytes Gr1low i) jouent un nouveau rôle clé de protection contre l'insulinorésistance ii) favorisent le gain de poids chez la souris sous régime obesogène. Ces monocytes favorisent vraisemblablement la fonction des macrophages M2 dans le tissu adipeux, diminuant son inflammation et favorisant ainsi son développement et la sensibilité à l'insuline.

Thesis (Ph. D.)--Cornell University, August, 2006. / Vita. Includes bibliographical references (leaves 116-143).

Reproduction de : Thèse doctorat : Médecine. Biochimie et biologie moléculaire : Reims : 2007. / Titre provenant de l'écran-titre. Bibliogr.